Laura Storoni

This inventor holds 15 USPTO granted patents and 2 published patent applications, plus 7 CIPO patents and 9 EPO patents, primarily in Nitric Oxide Donors. Top assignees: Nicox S.a., Nicox Science Ireland, Merck Sharp + Dohme Corp.. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laura Storoni. Retrieved from https://idiyas.com/inventor/laura-storoni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 2)

% Patents Active = 66.7

CIPO Patents = 7 (Patent Applications = 2)

EPO Patents = 9 (Patent Applications = 11)

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 16(Granted Patents)

Location History:

Cesano Maderno (mb), IT (2019)
Cesano Maderno, IT (2011 - 2024)

Company Filing History:

Nicox Science Ireland

patents

2 out of 2,405

Merck Sharp + Dohme Corp.

where one patent can have more than one assignee

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

Nitric Oxide

Phosphodiesterase Inhibitor

Prostaglandins

Ophthalmic Compositions

Carnosine Compounds

Quinone Compounds

Angiotensin II Receptor Antagonists

Pharmaceutical Innovations

Drug Formulations

Nitric Oxide Donors

Therapeutic Applications

Ophthalmology

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12642800 - Nitric oxide releasing phosphodiesterase type 5 inhibitor (2026-06-02),

2. 11980618 - Nitric oxide releasing phosphodiesterase type 5 inhibitor (2024-05-14),

3. 10610509 - Combinations of prostaglandins and nitric oxide donors (2020-04-07),

4. 10280138 - Nitric oxide donating derivatives of fluprostenol (2019-05-07),

5. 10093696 - Nitric oxide donating carnosine compounds (2018-10-09),

6. 10047047 - Nitric oxide donating derivatives of latanoprost free acid (2018-08-14),

7. 9895335 - Ophthalmic compositions containing a nitric oxide donor (2018-02-20),

8. 9598349 - Quinone based nitric oxide donating compounds for ophthalmic use (2017-03-21),

9. 9446015 - Quinone based nitric oxide donating compounds for ophthalmic use (2016-09-20),

10. 9266820 - Nitric oxide donor compounds (2016-02-23),

11. 9079821 - Quinone based nitric oxide donating compounds (2015-07-14),

12. 9061962 - Quinone based nitric oxide donating compounds (2015-06-23),

13. 8252825 - Angiotensin II receptor antagonists (2012-08-28),

14. 8003811 - Nitric oxide donor compounds (2011-08-23),

15. 7880014 - Angiotensin II receptor antagonists (2011-02-01),

Title: Laura Storoni: Innovator in Pharmaceutical Patents

Introduction: Laura Storoni, an influential inventor based in Cesano Maderno, Italy, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 14 patents, her work primarily focuses on innovative treatments concerning nitric oxide and its applications in medical therapies.

Latest Patents: Among her latest patents, two stand out prominently. The first is a "Nitric oxide releasing phosphodiesterase type 5 inhibitor," which pertains to novel PDE5 inhibitors designed to enhance nitric oxide release, potentially improving treatment options for various conditions. The second patent, "Combinations of prostaglandins and nitric oxide donors," addresses the development of compositions intended for treating glaucoma and elevated ocular pressure, utilizing a nitric oxide releasing isomannide derivative alongside prostaglandin analogs.

Career Highlights: Laura's professional journey includes pivotal roles in notable companies such as Nicox Science Ireland and Nicox S.A. Her dedication to pharmaceutical innovation has positioned her as a key figure in the industry, striving to improve therapeutic outcomes through her inventions.

Collaborations: Throughout her career, Laura has collaborated with esteemed colleagues, including Nicoletta Almirante and Elena Bastia. These partnerships have enhanced her research endeavors and contributed to the successful development of her patented technologies.

Conclusion: Laura Storoni exemplifies the spirit of innovation in the pharmaceutical industry. With her extensive patent portfolio and collaborative spirit, she continues to push the boundaries of medical advancements, aiming to provide better treatment options for patients worldwide.

Profile summary based on public USPTO records.